Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35653145

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2022 Aug 1
First author
Martin M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2022 Nov 1;8(11):1701. doi: 10.1001/jamaoncol.2022.4528.
    note
    Source null
    related pmid
    36173642
    relationship
    Comment in

Authors and identifiers

  1. name
    Martin M
    type
    Author
  2. name
    Hegg R
    type
    Author
  3. name
    Kim SB
    type
    Author
  4. name
    Schenker M
    type
    Author
  5. name
    Grecea D
    type
    Author
  6. name
    Garcia-Saenz JA
    type
    Author
  7. name
    Papazisis K
    type
    Author
  8. name
    Ouyang Q
    type
    Author
  9. name
    Lacko A
    type
    Author
  10. name
    Oksuzoglu B
    type
    Author
  11. name
    Reeves J
    type
    Author
  12. name
    Okera M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Martin M
    type
    Author
  2. name
    Hegg R
    type
    Author
  3. name
    Kim SB
    type
    Author
  4. name
    Schenker M
    type
    Author
  5. name
    Grecea D
    type
    Author
  6. name
    Garcia-Saenz JA
    type
    Author
  7. name
    Papazisis K
    type
    Author
  8. name
    Ouyang Q
    type
    Author
  9. name
    Lacko A
    type
    Author
  10. name
    Oksuzoglu B
    type
    Author
  11. name
    Reeves J
    type
    Author
  12. name
    Okera M
    type
    Author
bibliography ids
  1. nci-bib-1bce5812f1355903b1e015e2
book metadata
content sha256
f7f09ea238cb15c3116c56972ace671831fcb1f4b53fdd116be5c30c23b27499
document type
citation
dois
  1. 10.1001/jamaoncol.2022.1488
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35653145
immutable id
pubmed:35653145@f7f09ea238cb15c3116c56972ace671831fcb1f4b53fdd116be5c30c23b27499
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
8
name
JAMA oncology
nlm unique id
101652861
pages
1190-1194
volume
8
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2022 Nov 1;8(11):1701. doi: 10.1001/jamaoncol.2022.4528.
    note
    Source null
    related pmid
    36173642
    relationship
    Comment in
outcomes validated
false
pmid
35653145
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
0bc3935df87846d39e2117f43192db99c5df8e2a29d441fa069fc74f5d8ad110
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Aug 1
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35653145/
title
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.

Preserved source evidence · Not medical advice